A short reply clip on vision concerns tied to GLP-1 medications, a question that has followed reports of NAION eye stroke risk.
Recap by typeshit. Video by drzackoakey on TikTok.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
NYU's Dr Holly Lofton says some patients using gray-market reta saw no weight loss, and both experts warn against buying it online while it remains unapproved in the UK.
From a 600,000-veteran addiction study to fewer daily steps on smartwatches, scientists including Naveed Sattar weigh in on what GLP-1s do beyond appetite.
Loading…